Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Joachim Schorr, Mark Elander, Nancy Kelley

Premium

Caris Life Sciences has named Joachim Schorr to be its chief scientific officer.

Schorr formerly worked for two decades at Qiagen, where he was senior vice president of global research and development, managing director, and a member of the executive committee, among other positions. He will continue to serve as a scientific consultant for Qiagen.

Prior to joining Qiagen, Schorr worked at Hoechst, a German chemical-pharmaceuticals company, and was also co-founder of Coley Pharmaceuticals, EnPharma Pharmaceuticals, and QBM Cell Sciences. He holds a PhD in molecular biology and virology from the University of Cologne.


TrovaGene has appointed Mark Elander as chief scientific officer. Elander will direct the clinical development program for the company's portfolio of transrenal and urine-based molecular diagnostic assays. He will also oversee the ongoing clinical program for Trovagene's human papillomavirus carrier screening assay.

Elander previously served as chief scientific officer of BioTheranostics, a BioMérieux company. Prior to this, he was a research fellow at the RW Johnson Pharmaceutical Research Institute, part of Johnson & Johnson. He has also been a postdoctoral fellow in the department of molecular biology at Scripps Research Institute.


Nancy Kelley has stepped down from her post as founding executive director of the New York Genome Center. Kelley had been the driving force behind the center's creation and last November had also taken on the role of chief operating officer. She will continue to serve as an advisor and remain on the center's board of directors (IS 3/12/2013).

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.